宫颈癌患者与健康对照者肠道微生物多样性和属水平差异的识别
该研究对42例宫颈癌患者和46例健康女性对照者的粪便16S rDNA微生物组进行特征分析,发现宫颈癌患者α多样性显著高于对照(p<0.05),且该差异仅限于50岁以上女性(p<0.01);β多样性在两组间也显著不同(p<0.01)。Prevotella、Porphyromonas和Dialister在宫颈癌患者中显著富集,而Bacteroides、Alistipes和Lachnospiracea科成员在健康对照中显著富集。
要点
- 宫颈癌患者肠道菌群α多样性显著高于健康对照,差异限于50岁以上女性。
- β多样性(非加权Unifrac距离)在宫颈癌患者与对照间显著不同。
- Prevotella、Porphyromonas和Dialister在宫颈癌患者中富集,Bacteroides、Alistipes和Lachnospiracea科在健康对照中富集。
核心结论
- 研究提示宫颈癌患者与健康对照者肠道微生物群的多样性和组成存在差异;肠道微生物组与年龄的关联可能反映病因学或临床差异;这些发现为进一步研究宫颈癌中的肠道微生物组提供了依据。
研究设计与样本
- 研究对42例宫颈癌患者和46例健康女性对照者的粪便16S rDNA微生物组进行特征分析,采用Shannon多样性指数评估α多样性,采用非加权Unifrac距离的主坐标分析(PCoA)评估β多样性,采用线性判别分析效应大小(LEfSe)比较微生物类群的相对丰度。
主要发现
- 在宫颈癌患者中,细菌α多样性与年龄呈正相关(p=0.22),而在对照者中呈反向关系(p<0.01)。
- 宫颈癌患者的α多样性显著高于对照者(p<0.05),但按年龄分层后该关系仅限于50岁以上女性(p<0.01)。
- β多样性(非加权Unifrac距离)在宫颈癌患者与对照者间也显著不同(p<0.01)。
- 基于年龄和种族校正的LEfSe分析显示,多个类群在宫颈癌患者与对照者间显著不同:Prevotella、Porphyromonas和Dialister在宫颈癌患者中显著富集,而Bacteroides、Alistipes和Lachnospiracea科成员在健康受试者中显著富集。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study was to characterize variation in the gut microbiome of women with locally advanced cervical cancer and compare it to healthy controls. METHODS: We characterized the 16S rDNA fecal microbiome in 42 cervical cancer patients and 46 healthy female controls. Shannon diversity index (SDI) was used to evaluate alpha (within sample) diversity. Beta (between sample) diversity was examined using principle coordinate analysis (PCoA) of unweighted Unifrac distances. Relative abundance of microbial taxa was compared between samples using Linear Discriminant Analysis Effect Size (LEfSe). RESULTS: Within cervical cancer patients, bacterial alpha diversity was positively correlated with age (p = 0.22) but exhibited an inverse relationship in control subjects (p < 0.01). Alpha diversity was significantly higher in cervical cancer patients as compared to controls (p < 0.05), though stratification by age suggested this relationship was restricted to older women (>50 years; p < 0.01). Beta diversity (unweighted Unifrac; p < 0.01) also significantly differed between cervical cancer patients and controls. Based on age- and race-adjusted LEfSe analysis, multiple taxa significantly differed between cervical cancer patients and controls. Prevotella, Porphyromonas, and Dialister were significantly enriched in cervical cancer patients, while Bacteroides, Alistipes and members of the Lachnospiracea family were significantly enriched in healthy subjects. CONCLUSION: Our study suggests differences in gut microbiota diversity and composition between cervical cancer patients and controls. Associations within the gut microbiome by age may reflect etiologic/clinical differences. These findings provide rationale for further study of the gut microbiome in cervical cancer.
引用
- Sims TT, Colbert LE, Zheng J, et al. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls. Gynecol Oncol. 2019. PMID: 31500892. doi:10.1016/j.ygyno.2019.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。